Product

Gemcitabine+Cisplatin

Aliases

GC

1 clinical trial

1 indication

Indication

HER2 gene mutation

Clinical trial

Phase Ib/II Clinical Study of IAH0968 in Combination With Gemcitabine and Cisplatin for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors and Cholangiocarcinoma

Status: Recruiting, Estimated PCD: 2024-12-01